Skip to Content

10 Results Found

  • Article
  • Open Access
7 Citations
4,873 Views
19 Pages

Differential Effects of Aripiprazole on Electroencephalography-Recorded Gamma-Band Auditory Steady-State Response, Spontaneous Gamma Oscillations and Behavior in a Schizophrenia Rat Model

  • Florian W. Adraoui,
  • Kenza Hettak,
  • Geoffrey Viardot,
  • Magali Alix and ,
  • Sabrina Guiffard,
  • Benoît Meot,
  • Philippe L’Hostis,
  • Anne Maurin,
  • Eric Delpy and
  • Kevin Carvalho
  • + 6 authors+ 1 author

14 January 2024

The available antipsychotics for schizophrenia (SZ) only reduce positive symptoms and do not significantly modify SZ neurobiology. This has raised the question of the robustness and translational value of methods employed during drug development. Ele...

(This article belongs to the Special Issue Schizophrenia: From Molecular Mechanism to Therapy)
  • Review
  • Open Access
524 Views
19 Pages

N-Acetylcysteine in Schizophrenia: A Convergent Redox-Based Approach to Therapeutic Potential

  • Enric Rubio-Contreras,
  • Alonso Pérez-Toribio,
  • Patricia Álvaro,
  • Ana M. Cosialls and
  • Constanza Morén

2 October 2026

Schizophrenia (SCZ) remains one of the most disabling psychiatric disorders, in large part because current antipsychotics (APs) inadequately address negative symptoms and cognitive deficits. Converging evidence implicates a set of interconnected mech...

(This article belongs to the Section Antioxidant Enzyme Systems)
  • Article
  • Open Access
2,030 Views
12 Pages

25 September 2023

Inhibitory control plays an important role in controlling behaviors, and its impairment is a characteristic feature of schizophrenia. Such inhibitory control has been examined through the the stop-signal task, wherein participants are asked to suppre...

(This article belongs to the Special Issue Mathematical and Computational Neuroscience)
  • Review
  • Open Access
33 Citations
13,415 Views
30 Pages

The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders

  • Kevin Lee,
  • Zoe Mills,
  • Pangying Cheung,
  • Juliette E. Cheyne and
  • Johanna M. Montgomery

20 December 2022

NMDA-type glutamate receptors are critical for synaptic plasticity in the central nervous system. Their unique properties and age-dependent arrangement of subunit types underpin their role as a coincidence detector of pre- and postsynaptic activity d...

(This article belongs to the Special Issue NMDA Receptor-Based Therapeutics)
  • Review
  • Open Access
5 Citations
6,289 Views
21 Pages

Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia

  • Chitra Vinnakota,
  • Matthew R. Hudson,
  • Nigel C. Jones,
  • Suresh Sundram and
  • Rachel A. Hill

Glutamate N-methyl-D-aspartate receptor (NMDAR) hypofunction has been proposed to underlie schizophrenia symptoms. This theory arose from the observation that administration of NMDAR antagonists, which are compounds that inhibit NMDAR activity, repro...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
3 Citations
2,443 Views
17 Pages

Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity

  • Charlotte Day,
  • John-Paul Silva,
  • Rebecca Munro,
  • Brice Mullier and ,
  • Véronique Marie André,
  • Christian Wolff,
  • Gary J. Stephens and
  • Angela Bithell
  • + 3 authors+ 0 author

6 December 2024

Background/Objectives: Recent studies, typically using patient cerebrospinal fluid (CSF), have suggested that different autoantibodies (Aabs) acting on their respective receptors, may underlie neuropsychiatric disorders. The GluN1 (NR1) subunit of th...

(This article belongs to the Special Issue The 20th Anniversary of Pharmaceuticals—Advances in Pharmacology)
  • Article
  • Open Access
3 Citations
4,383 Views
15 Pages

Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity

  • Mercedeh Farhat Sabet,
  • Sumanta Barman,
  • Mathias Beller,
  • Sven G. Meuth and ,
  • Nico Melzer,
  • Orhan Aktas,
  • Norbert Goebels and
  • Tim Prozorovski
  • + 3 authors+ 0 author

23 December 2022

Anti-NMDA receptor (NMDAR) encephalitis is frequently associated with demyelinating disorders (e.g., multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein-associated disease (MOGAD)) with regard...

(This article belongs to the Special Issue Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders 2.0)
  • Review
  • Open Access
2,014 Views
16 Pages

3 October 2025

Schizophrenia (SZ) is a severe mental disorder associated with an array of symptoms characterized as positive, negative and cognitive dysfunctions. While SZ is a multifaceted disorder affecting several regions of the brain, altered thalamocortical sy...

(This article belongs to the Special Issue Cell Stress and Intervention in Neurological Disease: In Honor of Dr. Jang-Yen Wu for His Long and Distinguished Career in Neuroscience)
  • Review
  • Open Access
4 Citations
4,152 Views
17 Pages

Neuroplasticity Across the Autism–Schizophrenia Continuum

  • Evangelia Kesidou,
  • Nikolaos Mitsoudis,
  • Olympia Damianidou,
  • Charilaos Taloumtzis and ,
  • Marianna Tsakiridou,
  • Eleni Polyzoidou,
  • Eleni Grigoriadou,
  • Christos Bakirtzis,
  • Evangelia Spandou and
  • Constantina Simeonidou
  • + 5 authors+ 0 author

Plasticity is a fundamental property of the brain that enables the nervous system to respond appropriately to internal and external stimuli. It primarily involves changes at the synaptic level, mediated by a wide array of molecules, ultimately leadin...

(This article belongs to the Special Issue Multidisciplinary Approaches to Neurodegenerative Disorders)
  • Review
  • Open Access
18 Citations
10,728 Views
20 Pages

Schizophrenia is a complex neuropsychiatric disorder composed of primary cluster-positive symptoms, negative symptoms, disorganization, neurocognitive deficits, and social cognitive impairments. While traditional antipsychotics primarily target dopam...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)